Abstract:OBJECTIVE:To determine the role of extracellular signal-regulated kinase (ERK1/2) and p38 cascades in P2Y receptor-evoked effects on prostatic cancer cells.METHODS:Highly metastatic prostatic cancer cells 1E8 were transfected with dominant-negative MAPK kinase 1 (KA-MEK1). The activation of ERK1/2 was determined by Western blot technique. The role of ERK1/2 and p38 cascades in P2Y receptor-evoked effects on in vitro growth, colony formation and in vitro invasion was detected by cell count, soft agar colony formation assay and in vitro invasion assay. The effect of ATP on apoptosis was detected by flow cytometry.RESULTS:ERK1/2 activity in 1E8-KA-MEK1 transfectants was significantly suppressed by dominant-negative MEK1 transfection. After culture of 6 days, 1E8-KA-MEK1 transfectants exhibited a growth inhibition of 71% as compared with 1E8-pcDNA3 control. Moreover, after continuous treatment with 100 micro mol/L ATP for 6 days, the growth of 1E8-KA-MEK1 transfectants was further inhibited by an additional 17.2%. Pretreatment with 10 micro mol/L p38 inhibitor SB203580 antagonized the effect of ATP-induced additional growth inhibition, suggesting that ERK1/2 and p38 pathways play an important role in ATP-induced growth inhibition. In soft agar assay, 1E8-KA-MEK1 transfectants formed smaller colonies and exhibited a 75% decrease in colony formation (as compared with control). Further treatment with ATP or SB203580 plus ATP did not show significant effect on colony formation of 1E8-KA-MEK1 cells, implying a potential role of ERK1/2, instead of p38, in P2Y receptor-mediated inhibitory effect on colony formation. In in vitro invasion assay, 1E8-KA-MEK1 cells showed a 41% decrease in passing through matrigel-coated membranes, as compared with control. Treatment with ATP could restore their invasive ability, and this effect by ATP could be blocked by pretreatment with SB203580, indicating the involvement of both ERK1/2 and p38 pathways in invasive ability of prostatic cancer cells.CONCLUSIONS:The effects of ATP on in vitro growth, invasion and colony formation of prostatic cancer cells depend on the status of P2Y receptor activation by different treatment protocols. Continuous activation of P2Y receptor results in growth inhibition and transient activation of P2Y receptor stimulates in vitro invasion of prostatic cancer cells. Both ERK1/2 and p38 pathways are responsible for these effects; but only the ERK1/2 pathway is involved in regulation of colony formation of prostatic cancer cells.

[P2Y Purinergic Receptor Activated PI-3K/Akt Signaling Pathway in Regulation of Growth and Invasion of Prostatic Cancer].

[Effects of P2Y Receptor Activation on Prostatic Cancer Cells Requiring ERK1/2 or P38 Cascade].

[SHP2 and MKP5 in P2Y Purinergic Receptor-Mediated Prostate Cancer Invasion].

[ERK1/2 and P38 Kinases Are Important Regulators in P2Y Receptor-Mediated Prostate Cancer Invasion].

ERK1/2 and P38 Pathways Are Required for P2Y Receptor-Mediated Prostate Cancer Invasion.

P2Y2 Receptor Promotes Cell Invasion and Metastasis in Prostate Cancer Cells

Activation of the P2Y1 receptor induces apoptosis and inhibits proliferation of prostate cancer cells

P2y2 Receptor And Egfr Cooperate To Promote Prostate Cancer Cell Invasion Via Erk1/2 Pathway

Activation of P38 and C-Jun NH_2-terminal Kinase Mitogen-Activated Protein Kinases in Human Prostate Carcinoma Cell Lines with Different Metastatic Potentials

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

[Influence of Phosphoprotein Associated with Glycosphingolipid Microdomains 1 on Biologic Behavior of Human Prostatic Cancer Cell Line In-Vitro].

[Mechanism of the Activation of Extracellular Signal-Regulated Kinase (ERK) in Prostate Cancer Cell Lines with Different Metastatic Potential].

Phosphoprotein associated with glycosphingolipid microdomains 1 inhibits the proliferation and invasion of human prostate cancer cells in vitro through suppression of Ras activation.

Targeting PI3K/Akt signaling in prostate cancer therapy

P2Y purinergic signaling in prostate cancer: Emerging insights into pathophysiology and therapy

Important Roles of PI3K/AKT Signaling Pathway and Relevant Inhibitors in Prostate Cancer Progression

Ectonucleotidases and Purinergic Receptors in Mouse Prostate Gland

The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer

The glycolysis-related AMPK/ULK signaling pathway mediates the inhibitory effect of adiponectin in prostate cancer cells

PTEN and GSK3 Β : Key Regulators of Progression to Androgen-Independent Prostate Cancer

Inhibiting the P2X4 Receptor Suppresses Prostate Cancer Growth In Vitro and In Vivo, Suggesting a Potential Clinical Target